Glycoproteomic and Phenotypic Elucidation of B4GALNT2 Expression Variants in the SID Histo-Blood Group System
Open Access
- 1 April 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3936
Abstract
The Sda histo-blood group antigen (GalNAcβ1-4(NeuAcα2-3)Galβ-R) is implicated in various infections and constitutes a potential biomarker for colon cancer. Sd(a−) individuals (2–4% of Europeans) may produce anti-Sda, which can lead to incompatible blood transfusions, especially if donors with the high-expressing Sd(a++)/Cad phenotype are involved. We previously reported the association of B4GALNT2 mutations with Sd(a−), which established the SID blood-group system. The present study provides causal proof underpinning this correlation. Sd(a−) HEK293 cells were transfected with different B4GALNT2 constructs and evaluated by immunostaining and glycoproteomics. The predominant SIDnull candidate allele with rs7224888:T>C (p.Cys406Arg) abolished Sda synthesis, while this antigen was detectable as N- or O-glycans on glycoproteins following transfection of wildtype B4GALNT2. Surprisingly, two rare missense variants, rs148441237:A>G and rs61743617:C>T, found in a Sd(a−) compound heterozygote, gave results similar to wildtype. To elucidate on whether Sd(a++)/Cad also depends on B4GALNT2 alterations, this gene was sequenced in five individuals. No Cad-specific changes were identified, but a detailed erythroid Cad glycoprotein profile was obtained, especially for glycophorin-A (GLPA) O-glycosylation, equilibrative nucleoside transporter 1 (S29A1) O-glycosylation, and band 3 anion transport protein (B3AT) N-glycosylation. In conclusion, the p.Cys406Arg β4GalNAc-T2 variant causes Sda-deficiency in humans, while the enigmatic Cad phenotype remains unresolved, albeit further characterized.Keywords
Funding Information
- Knut och Alice Wallenbergs Stiftelse (2014.0312, 2020.0234)
- Vetenskapsrådet (2014-71X-14251, 2019-01683, K2014-68X08266-27-4, 2017-00955)
- American Liver Foundation (ALFSKANE-446521, ALFGBG-721971)
This publication has 45 references indexed in Scilit:
- Expression of the Human Sda -1,4-N-Acetylgalactosaminyltransferase II Gene is Dependent on the Promoter Methylation StatusGlycobiology, 2007
- Protein database searches using compositionally adjusted substitution matricesThe FEBS Journal, 2005
- Molecular Cloning of the Human 1,4 N-Acetylgalactosaminyltransferase Responsible for the Biosynthesis of the Sda Histo-Blood Group Antigen: The Sequence Predicts a Very Long Cytoplasmic DomainThe Journal of Biochemistry, 2003
- Disulfide Bonds of GM2 Synthase HomodimersJournal of Biological Chemistry, 2000
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997
- A Hemolytic Reaction Implicating Sda Antibody Missed by Immediate Spin CrossmatchVox Sanguinis, 1992
- Cad Antigen: Comparative Study of 50 Samples1Vox Sanguinis, 1975
- Cad Receptor in Thai Blood DonorsVox Sanguinis, 1974
- Haemolytic Transfusion Reaction Due to Anti‐SdaVox Sanguinis, 1970
- Anti‐Sda, a New Blood Group AntibodyVox Sanguinis, 1967